Synapse - Neil Segal

Results (210)

Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer

Journal Article

Cercek, A.; Goodman, K. A.; Hajj, C.; Weisberger, E.; Segal, N. H.; Reidy-Lagunes, D. L. ; Stadler, Z. K.; Wu, A. J.; Weiser, M. R.; Paty, P. B.; more...
Journal of the National Comprehensive Cancer Network (2014)

Fulltext@MSK | Save

Characterization of rectal cancer in patients with Lynch syndrome

Meeting Abstract

Stadler, Z. K.; Shia, J.; Goodman, K. A.; Cercek, A.; Segal, N. H.; Reidy, D. L.; Yaeger, R. D.; Nash, G. M.; Temple, L. K. F.; Kemeny, N. E.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Safety and clinical activity of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in combination with ipilimumab in patients (pts) with advanced melanoma (MEL)

Meeting Abstract

Wolchok, J. D.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Reed, K.; Burke, M. M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A phase I dose-escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) administered in combination with nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (Pts) with advanced refractory solid tumors

Meeting Abstract

Sanbom, R. E.; Sharfman, W. H.; Segal, N. H.; Hodi, F. S.; Wolchok, J. D.; Urba, W. J.; Fox, B. A.; Topalian, S. L.; Pardoll, D. M.; Covello, K. L.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A phase I study of the safety, tolerability, pharmacokinetics, and immunoregulatory activity of urelumab (BMS-663513) in subjects with advanced and/or metastatic solid tumors and relapsed/refractory B-cell non-Hodgkin's lymphoma (B-NHL)

Meeting Abstract

Melero, I.; Gangadhar, T. C.; Kohrt, H. E.; Segal, N. H.; Logan, T.; Urba, W. J.; Hodi, F. S.; Ott, P. A.; Perez-Gracia, J. L.; Wolchok, J. D.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Chemotherapy first, followed by chemoradiation (CRT) and then surgery, in the management of locally advanced rectal cancer (LARC)

Meeting Abstract

Cercek, A.; Goodman, K. A.; Hajj, C.; Weisberger, E.; Segal, N. H.; Reidy, D. L.; Stadler, Z. K.; Wu, A. J. C.; Weiser, M. R.; Paty, P.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Induction chemotherapy followed by chemoradiotherapy and total mesenteric excision for locally advanced rectal cancer with resectable metastases

Meeting Abstract

Hajj, C.; Cercek, A.; Saltz, L.; Segal, N. H.; Reidy, D. L.; Stadler, Z. K.; Kemeny, N. E.; Wu, A. J. C.; Weiser, M. R.; Paty, P.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A Phase I study of IMMU-130 (labetuzumab-SN38) anti-CEACAM5 antibody-drug conjugate (ADC) in patients with metastatic colorectal cancer (mCRC)

Meeting Abstract

Segal, N. H.; Verghis, J.; Govindan, S.; Maliakal, P.; Sharkey, R. M.; Wegener, W. A.; Goldenberg, D. M.; Saltz, L. B.
Cancer Research (2013)

Fulltext@MSK | Save

Initial results of a new antibody-drug conjugate (ADC), IMMU-130 (labetuzumab-SN38), in patients with metastatic colorectal cancer (mCRC)

Meeting Abstract

Segal, N. H.; Verghis, J.; Govindan, S.; Maliakal, P.; Sharkey, R. M.; Wegener, W. A.; Goldenberg, D. M.; Saltz, L. B.
European Journal of Cancer (2013)

Fulltext@MSK | Save

MEDI4736, an anti-PD-L1 antibody with modified Fc domain: Preclinical evaluation and early clinical results from a phase 1 study in patients with advanced solid tumors

Meeting Abstract

Khleif, S.; Lutzky, J.; Segal, N.; Antonia, S.; Blake-Haskins, A.; Stewart, R.; Robbins, P.; Shalabi, A.; Ibrahim, R.; Wolchok, J.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Neil Howard Segal

Results (210)

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract